Services

  • Mergers & Acquisitions
  • Equity Capital Markets
  • Debt Capital Markets

Sectors

  • Healthcare
  • Technology, Media & Telecom

Biography 

Eugene Izumo has nearly two decades of investment banking advisory and business management experience. As an advisor, he has led clients in M&A and capital raising deals totaling over $6 billion in combined transaction value. Eugene leverages his unique interdisciplinary experience in business operations management, public health, technology, education and corporate finance to help his clients navigate complex business strategy decisions and transaction processes.

Eugene's previous investment banking experience includes time at GCA Savvian (now Houlihan Lokey) where he worked with leading technology companies like Google, Zillow and IHS Markit, and at Citigroup where he worked with many of the largest global PE funds. He has also held leadership roles at McMaster-Carr, where he managed large teams in an operation doing nearly $1 billion in annual sales, and at several high-growth, venture-backed start-ups.

Eugene studied neuroscience and computer science at Brown University, received his teaching credential and Master's in Math Education from Loyola Marymount University, graduated with distinction from the UCLA Anderson School of Management, and completed the Global Healthcare Leadership Executive Program at Harvard.

Eugene has a deep passion for improving healthcare and education access and began his career as a middle school math teacher with Teach For America (TFA). He is currently an active member of various non-profits and charitable funds.

B. Riley Securities is a leading middle market investment bank that provides a full suite of corporate finance, advisory, sales and trading and equity research. Investment banking services include initial, secondary and follow-on offerings, institutional private placements, merger and acquisition (M&A) advisory, SPACs, corporate restructuring and recapitalization. B. Riley is nationally recognized and highly ranked for its proprietary equity research.